US Broker Ratings

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Assessing a 24.17% Potential Upside and Strong Market Position

Thermo Fisher Scientific Inc (NYSE: TMO) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a robust market capitalization of $183.03 billion,..

Intuitive Surgical, Inc. (ISRG) Investor Outlook: Exploring a 33.71% Potential Upside with Strong Revenue Growth

Investors with an eye on healthcare innovations and robotic-assisted surgical systems will find Intuitive Surgical, Inc. (NASDAQ: ISRG) an intriguing prospect. With a market capitalization of $150.39 billion, Intuitive Surgical..

The Cooper Companies, Inc. (COO) Stock Analysis: Can a 45% Potential Upside Justify Investor Interest?

The Cooper Companies, Inc. (NYSE: COO) stands out in the healthcare sector, primarily through its strong presence in the medical instruments and supplies industry. With a robust market capitalization of..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring a 16.85% Upside Potential

Teva Pharmaceutical Industries (NYSE: TEVA) is a heavyweight in the healthcare sector, specifically within the drug manufacturing industry, specializing in both specialty and generic medications. With a market capitalization of..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Unlocking a Promising 27.88% Upside

GE HealthCare Technologies Inc. (NYSE: GEHC) stands at the forefront of the medical device industry, offering a compelling investment opportunity with a potential upside of 27.88%, according to analyst projections...

Eli Lilly and Company (LLY) Stock Analysis: Evaluating a Pharmaceutical Giant with a 9.96% Upside Potential

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, particularly in the field of general drug manufacturing, has been capturing investor attention with its robust financial performance..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 19.50% Upside Potential

Align Technology, Inc. (NASDAQ: ALGN), a prominent name in the healthcare sector specializing in medical instruments and supplies, continues to capture investor attention with its robust market position and promising..

GSK plc (GSK) Stock Analysis: Evaluating a 14.64% Potential Upside in the Healthcare Giant

GSK plc (NYSE: GSK) stands as a formidable player in the global healthcare sector, with a market capitalization of $101.38 billion. As a major entity in the drug manufacturing industry,..

Summit Therapeutics Inc. (SMMT) Stock Analysis: A Potential 62.66% Upside in Biotech Innovation

Summit Therapeutics Inc. (NASDAQ: SMMT) is presenting a compelling opportunity for investors eyeing the biotechnology sector. With a market capitalization of $13.61 billion, this Miami-based biopharmaceutical company is at the..

DexCom, Inc. (DXCM) Investor Outlook: A Healthcare Stock with 12.28% Upside Potential

DexCom, Inc. (DXCM), a leader in the healthcare sector, is making significant strides in the medical device industry with its innovative continuous glucose monitoring (CGM) systems. With a market capitalization..

Waters Corporation (WAT) Stock Analysis: An Investor’s Guide to a 4.42% Potential Upside in the Healthcare Sector

Waters Corporation (WAT), a prominent player in the healthcare sector, is generating significant interest among investors with its robust revenue growth and solid analyst ratings. Operating within the diagnostics and..

Edwards Lifesciences (EW) Investor Outlook: A 11.78% Potential Upside in the Medical Device Sector

Edwards Lifesciences Corporation (NYSE: EW) stands as a significant player in the healthcare sector, specifically within the medical devices industry. With a robust market capitalization of $49.79 billion, this Irvine,..

HCA Healthcare, Inc. (HCA) Investor Outlook: Exploring a 34.98% Potential Upside

HCA Healthcare, Inc. (NYSE: HCA), a leading player in the Medical Care Facilities industry, presents a compelling investment opportunity for those looking to capitalize on the healthcare sector. With a..

BioNTech SE (BNTX) Stock Analysis: Potential 29% Upside with Promising Oncology Pipeline

BioNTech SE (NASDAQ: BNTX) has become a household name, particularly following its pivotal role in developing one of the first mRNA vaccines for COVID-19. However, for investors, the real story..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 27.83% Potential Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector may want to turn their attention to Takeda Pharmaceutical Company Limited (NYSE: TAK), a prominent player in the drug manufacturing industry with a..

Pfizer, Inc. (PFE)

⚠️ No article content returned.

..

Veeva Systems Inc. (VEEV): A 50% Upside Potential in Health Information Services – Investor Outlook

Veeva Systems Inc. (NYSE: VEEV) is making waves in the Healthcare sector, particularly within the Health Information Services industry. With a robust market capitalization of $28.45 billion, Veeva is a..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 33.54% Potential Upside in the Growing Healthcare Sector

Alcon Inc. (NYSE: ALC), a stalwart in the healthcare sector, specifically within the medical instruments and supplies industry, continues to capture investor attention with its robust market presence and promising..

Elevance Health, Inc. (ELV) Stock Analysis: Navigating Growth in the Healthcare Sector

Elevance Health, Inc. (NYSE: ELV), a leader in the healthcare plans industry, operates with a market capitalization of $85.39 billion, positioning itself as a formidable player within the U.S. healthcare..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Exploring a 22.6% Potential Upside Amidst Robust Revenue Growth

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a titan in the biotechnology sector, continues to capture investor attention with its innovative approach to treating serious diseases. With a market capitalization of $113.59..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds